Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice

INTRODUCTION: The purpose of this study was to document the efficacy and tolerability of the new fixed-combination (FC) brinzolamide 1%/timolol 0.5% as used in daily practice throughout Germany. METHODS: An open-label, multicenter, observational study of patients was performed that evaluated the tra...

Descripción completa

Detalles Bibliográficos
Autores principales: Lanzl, Ines, Raber, Thomas
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065570/
https://www.ncbi.nlm.nih.gov/pubmed/21468336
http://dx.doi.org/10.2147/OPTH.S16355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3065570/
https://www.ncbi.nlm.nih.gov/pubmed/21468336
http://dx.doi.org/10.2147/OPTH.S16355

Ejemplares similares